Clinical characteristics and risk factors associated with nosocomial COVID-19 infection in patients with hematological disorders in Japan.
Int J Hematol
; 114(6): 719-724, 2021 Dec.
Article
in English
| MEDLINE | ID: covidwho-1274955
ABSTRACT
Patients with cancer are considered at high risk of acquiring coronavirus disease (COVID-19). To identify patients who are likely to be diagnosed with severe COVID-19, we analyzed the risk factors for mortality in patients admitted to the hematology department at our institute. The mortality rate of all patients was as high as 62% (21 of the 34 patients), and most of these patients had malignant malignancies. Patients before an achievement of remission had a 10.8-fold higher risk of death than those in remission. The group receiving chemotherapy with steroids had a shorter survival time and had an 8.3-fold higher risk of death than that receiving chemotherapy without steroids. During the COVID-19 pandemic, it is necessary to carefully monitor or follow-up patients with active diseases and patients receiving steroid-containing chemotherapy.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Cross Infection
/
COVID-19
/
Glucocorticoids
/
Hematologic Diseases
Type of study:
Cohort study
/
Prognostic study
/
Randomized controlled trials
Topics:
Long Covid
Limits:
Female
/
Humans
/
Male
Country/Region as subject:
Asia
Language:
English
Journal:
Int J Hematol
Journal subject:
Hematology
Year:
2021
Document Type:
Article
Affiliation country:
S12185-021-03172-0
Similar
MEDLINE
...
LILACS
LIS